Literature DB >> 19624388

Coffee and cigarette use: association with suicidal acts in 352 Sardinian bipolar disorder patients.

Christopher Baethge1, Leonardo Tondo, Beatrice Lepri, Ross J Baldessarini.   

Abstract

OBJECTIVE: Abuse of illicit drugs and alcohol is prevalent in bipolar disorder (BPD) patients, and is an adverse prognostic factor. Much less is known about correlates of nicotine and caffeine consumption, but tobacco smoking is tentatively associated with suicidal behavior.
METHODS: Retrospective analysis of demographic and clinical factors among 352 longitudinally assessed DSM-IV types I and II BPD patients contrasted patients with versus without consumption of nicotine or caffeine, based on univariate comparisons and multiple regression modeling.
RESULTS: Current smoking (46%) and coffee drinking (74% of cases) were common, and significantly and independently associated with suicidal acts [coffee: odds ratio (OR) = 2.42, 95% confidence interval (CI): 1.15-5.09; smoking: OR = 1.79, CI: 1.02-3.15; both p < 0.001]. Risk increased with more smoking (cigarettes/day; r(s) = 0.383; p < 0.0001) and greater coffee consumption (cups/day; r(s) = 0.312; p = 0.008). Neither intake was related to yearly rates of all episodes, depressions, or manias.
CONCLUSIONS: This is the first report to associate suicidal acts with coffee consumption in BPD patients, and it confirmed an association with smoking. Pending further evidence, the findings underscore the importance of monitoring use of even legal and mildly psychotropic substances by BPD patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19624388     DOI: 10.1111/j.1399-5618.2009.00727.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  12 in total

1.  Suicidality in the prospective Zurich study: prevalence, risk factors and gender.

Authors:  Jules Angst; Michael P Hengartner; Jonathan Rogers; Ulrich Schnyder; Hans-Christoph Steinhausen; Vladeta Ajdacic-Gross; Wulf Rössler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-03-30       Impact factor: 5.270

Review 2.  The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations.

Authors:  Jaimee L Heffner; Jeffrey R Strawn; Melissa P DelBello; Stephen M Strakowski; Robert M Anthenelli
Journal:  Bipolar Disord       Date:  2011 Aug-Sep       Impact factor: 6.744

Review 3.  A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder.

Authors:  Ayal Schaffer; Erkki T Isometsä; Jean-Michel Azorin; Frederick Cassidy; Tina Goldstein; Zoltán Rihmer; Mark Sinyor; Leonardo Tondo; Doris H Moreno; Gustavo Turecki; Catherine Reis; Lars Vedel Kessing; Kyooseob Ha; Abraham Weizman; Annette Beautrais; Yuan-Hwa Chou; Nancy Diazgranados; Anthony J Levitt; Carlos A Zarate; Lakshmi Yatham
Journal:  Aust N Z J Psychiatry       Date:  2015-07-14       Impact factor: 5.744

4.  A Review of Smoking Cessation in Bipolar Disorder: Implications for Future Research.

Authors:  Tony P George; Becky S Wu; Andrea H Weinberger
Journal:  J Dual Diagn       Date:  2012-05-11

5.  Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines.

Authors:  Rachael W Taylor; Lindsey Marwood; Emanuella Oprea; Valeria DeAngel; Sarah Mather; Beatrice Valentini; Roland Zahn; Allan H Young; Anthony J Cleare
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-03       Impact factor: 5.176

6.  Coffee, caffeine, and risk of completed suicide: results from three prospective cohorts of American adults.

Authors:  Michel Lucas; Eilis J O'Reilly; An Pan; Fariba Mirzaei; Walter C Willett; Olivia I Okereke; Alberto Ascherio
Journal:  World J Biol Psychiatry       Date:  2013-07-02       Impact factor: 4.132

7.  Winning a won game: caffeine panacea for obesity syndemic.

Authors:  M Myslobodsky; A Eldan
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

8.  Smoking, Suicidality and Psychosis: A Systematic Meta-Analysis.

Authors:  Anoop Sankaranarayanan; Serafino Mancuso; Helen Wilding; Suhaila Ghuloum; David Castle
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

9.  Methylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate.

Authors:  Michael Kluge; Ulrich Hegerl; Christian Sander; Jens Dietzel; Roland Mergl; Istvan Bitter; Koen Demyttenaere; Ricardo Gusmão; Ana Gonzalez-Pinto; Victor Perez-Sola; Eduard Vieta; Georg Juckel; Ulrich S Zimmermann; Michael Bauer; Pascal Sienaert; Sónia Quintão; Marc-Andreas Edel; Csilla Bolyos; Jose Luis Ayuso-Mateos; Pilar López-García
Journal:  BMC Psychiatry       Date:  2013-02-27       Impact factor: 3.630

10.  Health-related quality of life in patients with dual diagnosis: clinical correlates.

Authors:  Irina Benaiges; Gemma Prat; Ana Adan
Journal:  Health Qual Life Outcomes       Date:  2012-09-05       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.